| Literature DB >> 849361 |
I K Tsang, C A Patterson, H B Stein, H S Robinson, D K Ford.
Abstract
Forty-four patients with definite or classic rheumatoid arthritis and failure to tolerate or respond to gold therapy were treated with D-penicillamine on a so-called go-slow, go-low regime. Seventeen patients tolerated the drug and had a 3-13 month follow-up assessment; 8 were markedly improved, 6 moderately or slightly improved, and 3 unimproved. Penicillamine had to be discontinued in 9 patients because of toxic side effects.Entities:
Mesh：
Substances：
Year: 1977 PMID： 849361 DOI： 10.1002/art.1780200205
Source DB: PubMed Journal: Arthritis Rheum ISSN： 0004-3591